Holdco Nuvo Group D.G Ltd
Holdco Nuvo Group D.G Ltd engages in the research, development, and marketing of medical devices for pregnancy monitoring in Israel, the United States, and internationally. It provides INVU platform, a remote pregnancy monitoring platform that provides expectant mothers with a self -administered wireless sensory band, which enables them and their obstetricians to monitor maternal and fetal heart … Read more
Market Cap & Net Worth: Holdco Nuvo Group D.G Ltd (NUVOQ)
Holdco Nuvo Group D.G Ltd (NASDAQ:NUVOQ) has a market capitalization of $33.26K ($33.26K) as of March 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #45005 globally and #14191 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Holdco Nuvo Group D.G Ltd's stock price $0.00 by its total outstanding shares 33261500 (33.26 Million).
Holdco Nuvo Group D.G Ltd Market Cap History: 2022 to 2025
Holdco Nuvo Group D.G Ltd's market capitalization history from 2022 to 2025. Data shows change from $340.93 Million to $33.26K (-93.68% CAGR).
Holdco Nuvo Group D.G Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Holdco Nuvo Group D.G Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
2035.38x
Holdco Nuvo Group D.G Ltd's market cap is 2035.38 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $358.23 Million | $176.00K | -$33.66 Million | 2035.38x | N/A |
Competitor Companies of NUVOQ by Market Capitalization
Companies near Holdco Nuvo Group D.G Ltd in the global market cap rankings as of March 19, 2026.
Key companies related to Holdco Nuvo Group D.G Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Holdco Nuvo Group D.G Ltd Historical Marketcap From 2022 to 2025
Between 2022 and today, Holdco Nuvo Group D.G Ltd's market cap moved from $340.93 Million to $ 33.26K, with a yearly change of -93.68%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $33.26K | -50.00% |
| 2024 | $66.52K | -99.98% |
| 2023 | $358.23 Million | +5.07% |
| 2022 | $340.93 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Holdco Nuvo Group D.G Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $33.26K USD |
| MoneyControl | $33.26K USD |
| MarketWatch | $33.26K USD |
| marketcap.company | $33.26K USD |
| Reuters | $33.26K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.